XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Stock award plan - (Tables)
6 Months Ended
Jun. 30, 2023
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2022

 

11,502,417

$

43.33

 

  

 

  

Granted

 

992,674

$

41.39

 

  

 

  

Exercised

 

(692,612)

$

29.37

 

  

 

  

Forfeited/Cancelled

 

(127,988)

$

49.84

 

  

 

  

Outstanding at June 30, 2023

 

11,674,491

$

43.92

 

6.27

years

$

44,184

Vested or Expected to vest at June 30, 2023

 

3,112,415

$

47.05

 

8.34

years

$

3,578

Exercisable at June 30, 2023

 

8,259,224

$

42.71

 

5.40

years

$

40,195

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Six months ended

    

June 30, 2023

Risk-free interest rate

 

3.54% - 3.88%

Expected volatility

 

53% - 54%

Expected term

 

5.5 years

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2022

2,516,336

$

45.67

Granted

 

1,943,288

40.00

Vested

 

(751,448)

46.46

Forfeited

 

(91,237)

42.49

Unvested at June 30, 2023

 

3,616,939

$

42.54

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2023

    

2022

    

2023

    

2022

Research and development

$

15,529

$

13,798

$

30,842

$

26,832

Selling, general and administrative

 

13,842

 

13,932

 

27,344

 

27,487

Total

$

29,371

$

27,730

$

58,186

$

54,319